scholarly journals 96-10: Low prevalence of pulmonary vein reconnection and active arrhythmogenic sources at first repeat procedure after stepwise catheter ablation for long-standing persistent atrial fibrillation

EP Europace ◽  
2016 ◽  
Vol 18 (suppl_1) ◽  
pp. i62-i62
Author(s):  
Martin Fiala ◽  
Ondrej Toman ◽  
Lukas Rybka ◽  
Veronika Bulkova ◽  
Libor Sknouril ◽  
...  
2016 ◽  
Vol 105 (9) ◽  
pp. 738-743 ◽  
Author(s):  
Kristina Wasmer ◽  
Dirk G. Dechering ◽  
Julia Köbe ◽  
Gerold Mönnig ◽  
Christian Pott ◽  
...  

EP Europace ◽  
2020 ◽  
Author(s):  
Koichi Inoue ◽  
Shungo Hikoso ◽  
Masaharu Masuda ◽  
Yoshio Furukawa ◽  
Akio Hirata ◽  
...  

Abstract Aims Previous studies could not demonstrate any benefit of more intensive ablation in addition to pulmonary vein isolation (PVI) including complex fractionated atrial electrogram (CFAE) and linear ablation for recurrence in the initial catheter ablation of persistent atrial fibrillation (AF). This study aimed to establish the non-inferiority of PVI alone to PVI plus these additional ablation strategies. Methods and results Patients with persistent AF who underwent an initial catheter ablation (n = 512, long-standing persistent AF; 128 cases) were randomly assigned in a 1:1 ratio to either PVI alone (PVI-alone group) or PVI plus CFAE and/or linear ablation (PVI-plus group). After excluding 15 cases who did not receive procedures, we analysed 249 and 248 patients, respectively. The primary endpoint was recurrence of AF, atrial flutter, and/or atrial tachycardia, and the non-inferior margin was set at a hazard ratio of 1.43. In the PVI-plus group, 85.1% of patients had linear ablation and 15.3% CFAE ablation. After 12 months, freedom from the primary endpoint occurred in 71.3% of patients in the PVI-alone group and in 78.3% in the PVI-plus group [hazard ratio = 1.56 (95% confidence interval: 1.10–2.24), non-inferior P = 0.3062]. The procedure-related complication rates were 2.0% in the PVI-alone group and 3.6% in the PVI-plus group (P = 0.199). Conclusion This randomized trial did not establish the non-inferiority of PVI alone to PVI plus linear ablation or CFAE ablation in patients with persistent AF, but implied that the PVI plus strategy was promising to improve the clinical efficacy (NCT03514693).


Sign in / Sign up

Export Citation Format

Share Document